Logo image of NEOV

NEOVOLTA INC (NEOV) Stock Fundamental Analysis

NASDAQ:NEOV - Nasdaq - US6406551068 - Common Stock - Currency: USD

3.19  -0.14 (-4.2%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NEOV. NEOV was compared to 93 industry peers in the Electrical Equipment industry. The financial health of NEOV is average, but there are quite some concerns on its profitability. NEOV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NEOV has reported negative net income.
NEOV had a negative operating cash flow in the past year.
NEOV had negative earnings in each of the past 5 years.
NEOV had a negative operating cash flow in each of the past 5 years.
NEOV Yearly Net Income VS EBIT VS OCF VS FCFNEOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of NEOV (-80.99%) is worse than 82.61% of its industry peers.
Looking at the Return On Equity, with a value of -98.60%, NEOV is doing worse than 64.13% of the companies in the same industry.
Industry RankSector Rank
ROA -80.99%
ROE -98.6%
ROIC N/A
ROA(3y)-76.82%
ROA(5y)-101.61%
ROE(3y)-104.1%
ROE(5y)-119.8%
ROIC(3y)N/A
ROIC(5y)N/A
NEOV Yearly ROA, ROE, ROICNEOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

NEOV has a Gross Margin (23.77%) which is in line with its industry peers.
NEOV's Gross Margin has improved in the last couple of years.
NEOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.68%
GM growth 5YN/A
NEOV Yearly Profit, Operating, Gross MarginsNEOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for NEOV has been increased compared to 1 year ago.
The number of shares outstanding for NEOV has been increased compared to 5 years ago.
NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NEOV Yearly Shares OutstandingNEOV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NEOV Yearly Total Debt VS Total AssetsNEOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 84.18 indicates that NEOV is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 84.18, NEOV belongs to the top of the industry, outperforming 98.91% of the companies in the same industry.
NEOV has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
NEOV has a Debt to Equity ratio of 0.12. This is in the better half of the industry: NEOV outperforms 63.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 84.18
ROIC/WACCN/A
WACCN/A
NEOV Yearly LT Debt VS Equity VS FCFNEOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 12.02 indicates that NEOV has no problem at all paying its short term obligations.
With an excellent Current ratio value of 12.02, NEOV belongs to the best of the industry, outperforming 96.74% of the companies in the same industry.
A Quick Ratio of 5.94 indicates that NEOV has no problem at all paying its short term obligations.
NEOV has a Quick ratio of 5.94. This is amongst the best in the industry. NEOV outperforms 93.48% of its industry peers.
Industry RankSector Rank
Current Ratio 12.02
Quick Ratio 5.94
NEOV Yearly Current Assets VS Current LiabilitesNEOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NEOV have decreased strongly by -72.45% in the last year.
Looking at the last year, NEOV shows a very negative growth in Revenue. The Revenue has decreased by -19.28% in the last year.
Measured over the past years, NEOV shows a very negative growth in Revenue. The Revenue has been decreasing by -18.13% on average per year.
EPS 1Y (TTM)-72.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.19%
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-18.13%
Revenue growth 5YN/A
Sales Q2Q%5.32%

3.2 Future

NEOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.42% yearly.
NEOV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 104.65% yearly.
EPS Next Y-57.14%
EPS Next 2Y41.42%
EPS Next 3Y34.42%
EPS Next 5YN/A
Revenue Next Year71.43%
Revenue Next 2Y155.65%
Revenue Next 3Y104.65%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEOV Yearly Revenue VS EstimatesNEOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEOV Yearly EPS VS EstimatesNEOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEOV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEOV Price Earnings VS Forward Price EarningsNEOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEOV Per share dataNEOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

A more expensive valuation may be justified as NEOV's earnings are expected to grow with 34.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y34.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEOV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOVOLTA INC

NASDAQ:NEOV (2/21/2025, 11:34:02 AM)

3.19

-0.14 (-4.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-07 2025-02-07/amc
Earnings (Next)N/A N/A
Inst Owners4.76%
Inst Owner Change8.33%
Ins Owners14.84%
Ins Owner Change6.8%
Market Cap106.61M
Analysts82.86
Price Target7.65 (139.81%)
Short Float %3.45%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.55%
Min EPS beat(2)-47.06%
Max EPS beat(2)1.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)41.25%
Min Revenue beat(2)-27.7%
Max Revenue beat(2)110.2%
Revenue beat(4)1
Avg Revenue beat(4)-7.7%
Min Revenue beat(4)-94.43%
Max Revenue beat(4)110.2%
Revenue beat(8)2
Avg Revenue beat(8)-23.19%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)57.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10%
EPS NY rev (3m)-120%
Revenue NQ rev (1m)-38.46%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-47.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 42.22
P/FCF N/A
P/OCF N/A
P/B 32.3
P/tB 32.3
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.08
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.99%
ROE -98.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.77%
FCFM N/A
ROA(3y)-76.82%
ROA(5y)-101.61%
ROE(3y)-104.1%
ROE(5y)-119.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.68%
GM growth 5YN/A
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.02
Quick Ratio 5.94
Altman-Z 84.18
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.19%
EPS Next Y-57.14%
EPS Next 2Y41.42%
EPS Next 3Y34.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-18.13%
Revenue growth 5YN/A
Sales Q2Q%5.32%
Revenue Next Year71.43%
Revenue Next 2Y155.65%
Revenue Next 3Y104.65%
Revenue Next 5YN/A
EBIT growth 1Y-66.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.15%
EBIT Next 3Y44.23%
EBIT Next 5YN/A
FCF growth 1Y-43.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.37%
OCF growth 3YN/A
OCF growth 5YN/A